Early Onset Colorectal Cancer Screening: What’s New, What Should We Do?

Document Type : Mini Review


Department of Surgery, Sebelas Maret University, Indonesia



In either men or women in the United States, colorectal cancer (also known as CRC) is the third largest cause of death from cancer-related causes. Screening programs that start at age 50 and have an average risk have been shown to lower the incidence and death of colorectal cancer in people older than 50 years of age. On the other hand, the incidence of colorectal cancer in people younger than 50 years of age (early onset colorectal cancer, or eoCRC) has recently and substantially increased.
Epidemiologic studies of eoCRC suggest that the cancer is most prevalent in the distal colon and rectum, and that it is associated with a number of risk factors that can be modified, such as diabetes, obesity, diet, sedentary time, alcohol intake, and smoking. The data covering the potential risk factors of prior antibiotic exposure and alterations to the microbiome or direct carcinogen exposure are still in the process of being gathered. It's possible that a delay in diagnosis or more aggressive tumor biology led to the aggressive clinicopathologic characteristics of eoCRC that were observed at presentation. When matched for stage, the outcomes of patients with EoCRC are comparable to those of patients with loCRC; nevertheless, the overall mortality rate is higher due to a higher frequency of advanced illness at a younger presentation, which results in more life-years lost.




    1. Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. Early-onset colorectal cancer in young individuals. Molecular oncology. 2019;13(2):109-31.
    2. Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer. Gastroenterology. 2021;160(4):1041-9.
    3. Akimoto N, Ugai T, Zhong R, Hamada T, Fujiyoshi K, Giannakis M, et al. Rising incidence of early-onset colorectal cancer - a call to action. Nature reviews Clinical oncology. 2021;18(4):230-43.
    4. Venugopal A, Carethers JM. Epidemiology and biology of early onset colorectal cancer. EXCLI journal. 2022;21:162-82.
    5. Muller C, Ihionkhan E, Stoffel EM, Kupfer SS. Disparities in Early-Onset Colorectal Cancer. Cells. 2021;10(5).
    6. Jeong MA, Kang HW. [Early-onset Colorectal Cancer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2019;74(1):4-10.
    7. Willauer AN, Liu Y, Pereira AAL, Lam M, Morris JS, Raghav KPS, et al. Clinical and molecular characterization of early-onset colorectal cancer. Cancer. 2019;125(12):2002-10.
    8. Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Translational oncology. 2021;14(10):101174.
    9. Puzzono M, Mannucci A, Grannò S, Zuppardo RA, Galli A, Danese S, et al. The Role of Diet and Lifestyle in Early-Onset Colorectal Cancer: A Systematic Review. Cancers. 2021;13(23).
    10. Saraiva MR, Rosa I, Claro I. Early-onset colorectal cancer: A review of current knowledge. World journal of gastroenterology. 2023;29(8):1289-303.
    11. Ullah F, Pillai AB, Omar N, Dima D, Harichand S. Early-Onset Colorectal Cancer: Current Insights. Cancers. 2023;15(12).
    12. Done JZ, Fang SH. Young-onset colorectal cancer: A review. World journal of gastrointestinal oncology. 2021;13(8):856-66.
    13. Garrett C, Steffens D, Solomon M, Koh C. Early-onset colorectal cancer: why it should be high on our list of differentials. ANZ journal of surgery. 2022;92(7-8):1638-43.
    14. Siegel RL, Jakubowski CD, Fedewa SA, Davis A, Azad NS. Colorectal Cancer in the Young: Epidemiology, Prevention, Management. American Society of Clinical Oncology educational book American Society of Clinical Oncology Annual Meeting. 2020;40:1-14.
    15. Wu CW, Lui RN. Early-onset colorectal cancer: Current insights and future directions. World journal of gastrointestinal oncology. 2022;14(1):230-41.